GDUFA Research Outcomes
Inhalation Products
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to locally acting generic products administered via the inhalation route, including orally inhaled products.
-
Generic Drug Development for Respiratory Products: US Food and Drug Administration Update
Witzmann, Kimberly
-
Critical Importance of Excipients in Generic Product Development- Now and in the Future
Witzmann, Kimberly
-
Overview of Regulatory and User-Interface Considerations, and the Role of Comparative Analyses, in Developing a Generic Drug-Device Combination Product in an ANDA
Witzmann, Kimberly
-
Generic Drug Development For Respiratory Products, US Food And Drug Administration Update
Witzmann, Kimberly
-
The Role of Comparative Analyses for Evaluation of Generic Drug-Device Combinations in an ANDA
Witzmann, Kimberly
-
Overcoming Barriers to Entry for Complex Generic Oral Inhalation Drug Products
Witzmann, Kimberly
-
Predictive Dissolution Methods fro OINDPs
Witzmann, Kimberly
-
Impact of Excipients on Inhalation Products
Witzmann, Kimberly
-
Credibility Establishment for Computational Fluid Dynamics Models of Complex Generic Drug Delivery
Walenga, Ross
-
Impact of Orally Inhaled and Nasal Drug Product PBPK Models on Product Development and Regulatory Decision Making
Walenga, Ross